Asker Healthcare Group AB's Nomination Committee for the Annual General Meeting 2027 has, in accordance with the instruction for the nomination committee, been appointed based on the ownership structure as of 31 August 2026.
The Nomination Committee consists of:
Johan Hesser, Interogo Long-Term Equity
Patrik Jönsson, SEB Funds AB
Richard Torgerson, Nordea Funds
Mikael Stöhr, Chairman of the Board of Asker Healthcare Group AB
Shareholders having appointed members to the Nomination Committee represent approximately 51 percent of the voting rights for all shares of Asker Healthcare Group AB.
Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nomination.committee@asker.com, or by post to Asker Healthcare Group, Att. Nomination Committee, Svärdvägen 3A, SE-182 33 Danderyd, Sweden. In order for proposals to be considered by the nomination committee, they should be received in due time before the Annual General Meeting, no later than 31 January 2027.
The Annual General Meeting of Asker Healthcare Group AB will be held on 5 May 2027.
For further information, please contact:
Emma Rheborg, Head of Communication Asker Healthcare Group
Phone: +46 73 313 62 17
E-mail: emma.rheborg@asker.com
The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CEST on 18 September 2026.
Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group - driving progress in the healthcare sector. The group has more than 5 000 employees in 19 countries and revenues amounting to SEK 18 billion.